Eleonora Sosa Cuevas

MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma

Camille Niveau, Mélanie Cettour-Cave, Stéphane Mouret et al. · Nature Communications · 2025 · 40 citations · Full text

Medicine, Immunology, Oncology +17

BDCA1⁺ cDC2s, BDCA2⁺ pDCs and BDCA3⁺ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients

Eleonora Sosa Cuevas, Laurissa Ouaguia, Stéphane Mouret et al. · Clinical & Translational Immunology · 2020 · 25 citations · Full text

Medicine, Immunology, Oncology +14

Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80⁺ PDL1⁻)‐pDC subset negatively correlated with clinical outcomes in melanoma patients

Eleonora Sosa Cuevas, Nathalie Bendriss‐Vermare, Stéphane Mouret et al. · Clinical & Translational Immunology · 2022 · 18 citations · Full text

Medicine, Immunology, Oncology +17

Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients

Eleonora Sosa Cuevas, Jenny Valladeau‐Guilemond, Stéphane Mouret et al. · Frontiers in Immunology · 2022 · 16 citations · Full text

Life Sciences, Immunology, Oncology +17

The melanoma tumor glyco-code impacts human dendritic cells’ functionality and dictates clinical outcomes

Eleonora Sosa Cuevas, Benoît Roubinet, Stéphane Mouret et al. · Frontiers in Immunology · 2023 · 14 citations · Full text

Life Sciences, Immunology, Oncology +17